Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Norepinephrine in Sepsis-induced Hypotension
NCT05774054Completed
- Sponsor
- Tanta University
- Start
- May 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of norepinephrine in septic shock (2 arms), sponsored by Tanta University. Primary endpoint: Duration to achieve the target Mean Arterial Pressure (MAP) at 24 hours. Started May 2021; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05774054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774054.